Younger Breast Cancer Survivors Suffer More Bone Loss From Treatment
TUESDAY, Dec. 11, 2018 -- Younger breast cancer survivors are at increased risk for osteoporosis -- weak, brittle bones -- due to breast cancer treatments, new study finds. The study included 211 women who had been diagnosed with breast cancer... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 11, 2018 Category: General Medicine Source Type: news

Research confirms a link between chemical hair colors and an increased risk for cancer
(Natural News) You may want to think twice about the nice-looking dye you want to try out on your hair. An article in Natural Health 365 warned that the synthetic chemicals used in hair coloring can make their users much more vulnerable to several types of cancer. This is bad given that three out of... (Source: NaturalNews.com)
Source: NaturalNews.com - December 11, 2018 Category: Consumer Health News Source Type: news

Apixaban Significantly Reduces VTE in Cancer Patients Apixaban Significantly Reduces VTE in Cancer Patients
Cancer patients at risk for venous thromboembolism significantly benefited from apixaban compared with placebo. But routine primary thromboprophylaxis is not yet recommended.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 11, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Breast cancer risk may increase after childbirth, study finds
The study looked at data from nearly 890,000 women of different ages (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - December 11, 2018 Category: Consumer Health News Source Type: news

Lung cancer - the 10p vegetable to add to your shopping list to avoid symptoms
LUNG CANCER risk could be lowered by making some diet changes, and by giving up smoking, if you ’re a smoker. You could lower your chances of lung cancer symptoms, including coughs and chest pain, by eating more of this cheap vegetable. Are you at risk? (Source: Daily Express - Health)
Source: Daily Express - Health - December 11, 2018 Category: Consumer Health News Source Type: news

Bittersweet Ending to Asbestos Cleanup in Libby, Montana
The asbestos cleanup of Libby, Montana, is coming to a celebrated close. The U.S. Environmental Protection Agency will soon end the largest, longest-running asbestos cleanup project in American history. It’s a bittersweet ending to what is left behind. The 19-year, $600 million EPA Superfund project aimed to right the wrongs created by the shuttered W.R. Grace and Co. vermiculite mine. Once the lifeblood of the community, it also became a cold-hearted killer. Although the mine was closed almost 30 years ago, health officials have since documented more than 400 deaths linked to asbestos-related diseases such as mes...
Source: Asbestos and Mesothelioma News - December 11, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Medical News Today: What is appendix cancer?
Appendix cancer is very rare, and many people experience no symptoms in the early stages. Doctors often diagnose this cancer when it spreads to other organs or after they remove a person ’s appendix due to appendicitis. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 11, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Breast cancer risk may increase for women after recent childbirth, study finds
New research led by doctors from the University of North Carolina and the Institute of Cancer Research in London shows women who have babies may have a greater risk for breast cancer, compared to women without children. The study looked at data from nearly 890,000 women of different ages. It found the risk continues for more than two decades after childbirth. Dr. David Agus, director of USC Norris Westside Cancer Center, joins "CBS This Morning" to discuss the findings. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - December 11, 2018 Category: Consumer Health News Source Type: news

Visual Registration & #43; Image Fusion Best for Targeted Biopsy
TUESDAY, Dec. 11, 2018 -- The combination of visual registration and image fusion should be used when targeted biopsy is being performed on men with suspected prostate cancer, according to a study published online Dec. 5 in European Urology. Sami... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 11, 2018 Category: Pharmaceuticals Source Type: news

Breast CA Detection Rate Up With Digital Mammography in the U.K.
TUESDAY, Dec. 11, 2018 -- Digital mammography (DM) has increased the overall cancer detection rate by 14 percent, with higher detection rates for grade 1 and 2 invasive cancers, according to research published online Dec. 11 in Radiology. Roger G.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 11, 2018 Category: Pharmaceuticals Source Type: news

Uganda: Cancer Institute Makes Case for New Charges
[Monitor] Kampala -The Uganda Cancer Institute (UCI) has said the new charges imposed on patients seeking radiotherapy treatment are meant to make the unit self-sustaining. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 11, 2018 Category: African Health Source Type: news

Cancer survivor, 44, felt a lump in her breast after she picked a cup of tea off her bedside table  
Nicola Fairbrass, 44, of Oakwood, Derby, initially dismissed the lump as a cyst but went to her GP two weeks later when the mass grew. She was diagnosed with breast cancer last January. (Source: the Mail online | Health)
Source: the Mail online | Health - December 11, 2018 Category: Consumer Health News Source Type: news

Amgen contributes $2 million to groundbreaking program providing cancer patients of all backgrounds access to U.S. clinical trials
Amgen (NASDAQ:AMGN) and the Lazarex Cancer Foundation, a non-profit organization focused on improving patient access to cancer clinical trials, have teamed up to support more equitable access to clinical trials for cancer patients in the U.S. Through a corporate donation, Amgen has contributed $2 million to Lazarex's IMPACT (IMproving Patient Access to Cancer Clinical Trials) program, (Source: World Pharma News)
Source: World Pharma News - December 11, 2018 Category: Pharmaceuticals Tags: Featured Amgen Business and Industry Source Type: news

Metro East to get $17 million cancer center
A Metro East hospital is set to open a $17 million radiation oncology clinic in 2020. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 11, 2018 Category: American Health Authors: Brian Robbins Source Type: news

Medical News Today: These tiny sensors may detect cancer early
Researchers use nanosensors to detect intracellular interactions that may signal cancer very early on. Their results may help detect lymphocytic leukemia. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 11, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Drug cocktail turns off the juice to cancer cells
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth - this was discovered by researchers from the University of Basel's Biozentrum two years ago. In a follow-up study, recently published in Cell Reports, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply. (Source: World Pharma News)
Source: World Pharma News - December 11, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Breast cancer shoots up 80% for women after giving birth for the first time, study reveals   
Childbirth has mysterious affects on breast cancer risks. Over awoman's lifetime, having children lowers risks, but after her fist baby, risks are higher, a University of North Carolina study reveals. (Source: the Mail online | Health)
Source: the Mail online | Health - December 11, 2018 Category: Consumer Health News Source Type: news

Nigeria: Janssen Hosts Prostate Cancer Awareness Event 'More Time for Life'
[Premium Times] On Saturday 8th December 2018, Janssen, one of the Pharmaceutical Companies of Johnson& Johnson, invited guests to 'More Time For Life!', a one day health and social networking event that aimed to encourage men to be more proactive in taking control of their health in general and prostate health in particular. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 11, 2018 Category: African Health Source Type: news

Catnip: The 'Why' Behind Cats' Favorite High
Title: Catnip: The 'Why' Behind Cats' Favorite HighCategory: Health NewsCreated: 12/10/2018 12:00:00 AMLast Editorial Review: 12/11/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - December 11, 2018 Category: Cancer & Oncology Source Type: news

Advanced MRI better option for brain tumor recurrence
Is PET or MRI better for detecting tumor recurrence in patients with brain...Read more on AuntMinnie.comRelated Reading: DWI-MRI may be best for indeterminate lung nodules How effective is PET/MRI for rectal cancer? MRI shows promise for lung cancer screening Can whole-body MRI be used in oncologic staging? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 11, 2018 Category: Radiology Source Type: news

RaySearch to add treatment control feature
Radiation therapy software developer RaySearch Laboratories said it will develop...Read more on AuntMinnie.comRelated Reading: RaySearch to unveil new deep-learning software at ASTRO RaySearch signs Canadian cancer center RaySearch, Canon sign collaboration pact RaySearch signs Swedish Cancer Institute RaySearch to highlight software upgrades at AAPM (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 11, 2018 Category: Radiology Source Type: news

Mental illness may double need for CT lung screening
U.S. patients with a mental health illness have a considerably higher smoking...Read more on AuntMinnie.comRelated Reading: MRI shows promise for lung cancer screening CT lung cancer screening foiled by low adherence CT lung screening reduces cancer mortality in men by 26% Access to CT lung screening varies by population density CT lung screening may benefit racial minorities most (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 11, 2018 Category: Radiology Source Type: news

How a tiny seaweed-dwelling animal led this East Bay startup to HIV, cancer
The synthetic sibling of an expensive molecule harvested from a tiny seaweed-dwelling animal could lead to next-generation cancer drugs or a functional cure for HIV, an East Bay company believes. Those lofty targets are years in the distance for startup BryoLogyx Inc., but the company said it will expand preclinical testing next year with synthetic bryostatin, eyeing more investor and scientific interest. BryoLogyx bought exclusive rights to synthetic bryostatin and its potential offshoot s from… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 11, 2018 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

How a tiny seaweed-dwelling animal led this East Bay startup to HIV, cancer
The synthetic sibling of an expensive molecule harvested from a tiny seaweed-dwelling animal could lead to next-generation cancer drugs or a functional cure for HIV, an East Bay company believes. Those lofty targets are years in the distance for startup BryoLogyx Inc., but the company said it will expand preclinical testing next year with synthetic bryostatin, eyeing more investor and scientific interest. BryoLogyx bought exclusive rights to synthetic bryostatin and its potential offshoot s from… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 11, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news

Breast Cancer Survivors May Have Lingering Mental Health Issues Breast Cancer Survivors May Have Lingering Mental Health Issues
Breast cancer survivors may be more likely to experience anxiety, depression, sleep troubles and other mental health issues than women who have not been diagnosed with the disease, a research review suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 11, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Androgen-Deprivation Therapy Linked to Increased Risk of Heart Failure Androgen-Deprivation Therapy Linked to Increased Risk of Heart Failure
The use of androgen-deprivation therapy (ADT) in men with prostate cancer is associated with an increased risk of heart failure, researchers from Taiwan report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 11, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Digital mammography increases breast cancer detection
(Radiological Society of North America) The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United Kingdom without increasing the recall rate, according to a major new study. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2018 Category: Cancer & Oncology Source Type: news

Novel technique may significantly reduce breast biopsies
(Radiological Society of North America) A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce unnecessary breast biopsies, according to a new study. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2018 Category: Cancer & Oncology Source Type: news

Stop sterilizing your dust
(Northwestern University) A new Northwestern University study has found that an antimicrobial chemical called triclosan is abundant in dust -- and linked to changes in its genetic makeup. The result is dust with organisms that could cause an antibiotic-resistant infection. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2018 Category: Cancer & Oncology Source Type: news

Cells 'dance' through endocytosis, metastasis
(American Society for Cell Biology) Celldance, a program of the American Society for Cell Biology (ASCB), helps researchers tell the story of their research through video. Two new Celldance videos premiere at the Society's annual meeting, held jointly with the European Molecular Biology Organisation (EMBO), in San Diego, CA. Videos will be shown Dec 11 at 1:00 pm in Theatre 3 of the Learning Center at the San Diego Convention Center. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2018 Category: Cancer & Oncology Source Type: news

Loss of two genes drives a deadly form of colorectal cancer, reveals a potential treatment
(Sanford Burnham Prebys Medical Discovery Institute) Scientists from Sanford Burnham Prebys Medical Discovery Institute (SBP), in collaboration with clinicians from Scripps Clinic, have identified that the loss of two genes drives the formation of serrated colorectal cancer--yielding potential biomarkers. The research has also identified a combination treatment that has treated the cancer in mice. The study published today in Immunity. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2018 Category: Cancer & Oncology Source Type: news

Successful anti-PD-1 therapy requires interaction between CD8+ T cells and dendritic cells
(Massachusetts General Hospital) A team led by a Massachusetts General Hospital investigator has found that successful cancer immunotherapy targeting the PD-1 molecule requires interaction between cytotoxic CD8+ T cells, which have been considered the primary therapeutic target, and dendritic cells, critical activators of T cell response. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2018 Category: Cancer & Oncology Source Type: news

The source of stem cells points to two proteins
(Michigan State University) While other animal embryos grow outside the mother, their embryonic cells can get right to work accepting assignments, such as head, tail or vital organ. By contrast, mammalian embryos must first choose between forming the placenta or creating the baby. New research at MSU has pinpointed two proteins that are the keys to this decision making. The process of assigning cells to placenta or baby is important because that is when pluripotent cells are made. These adaptable pluripotent cells are critical to stem cell research. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2018 Category: Cancer & Oncology Source Type: news

Pushing closer to a new cancer-fighting strategy
(Johns Hopkins Medicine) A molecular pathway that's frequently mutated in many different forms of cancer becomes active when cells push parts of their membranes outward into bulging protrusions, Johns Hopkins researchers report in a new study. The finding, published Nov. 7 in Nature Communications, could eventually lead to new targets for cancer-fighting therapeutics. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2018 Category: Cancer & Oncology Source Type: news

Researchers use computer model to predict prostate cancer progression
(University of Copenhagen The Faculty of Health and Medical Sciences) An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the course of disease for prostate cancer. The model is currently being implemented at a prostate cancer clinic in Germany. The researchers have also found the enzyme that appears to trigger some of the first mutations in prostate cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2018 Category: Cancer & Oncology Source Type: news

ESMO Immuno-Oncology Congress showcases new technologies set to improve cancer treatment
(European Society for Medical Oncology) Innovation in immuno-oncology is exploding and new technologies that are set to benefit many patients with cancer are being showcased in the highly diverse array of topics to be discussed at the ESMO Immuno-Oncology Congress, to be held 13-16 December in Geneva, Switzerland. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2018 Category: Cancer & Oncology Source Type: news

Integral Molecular partners with Merus to discover novel therapeutic monoclonal antibodies
(Integral Molecular) Integral Molecular, the industry leader in the discovery of monoclonal antibodies (MAbs) against membrane proteins, and Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, announced that they have entered into a collaboration on multiple undisclosed targets. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2018 Category: Cancer & Oncology Source Type: news

Harrington Discovery Institute at University Hospitals announces 2019 grant funding
(University Hospitals Cleveland Medical Center) The Harrington Discovery Institute at University Hospitals has announced the 2019 Harrington Scholar-Innovator Award recipients. Projects supported by the awards include new therapeutics to treat metabolic disorders, autoimmune disorders and cancer, and new approaches to eradicate parasitic diseases in developing countries. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2018 Category: Cancer & Oncology Source Type: news

ToxicDocs: World's largest database exposing once-secret documents on industrial poisons
(Columbia University) ToxicDocs consists of more than 20 million discovery documents from myriad lawsuits made public once they were introduced in court but were extremely hard for the public to access. The data includes internal memos, unpublished scientific studies, planning reports for public relations campaigns, meeting minutes and presentations--some dating back to the 1920s--related to the introduction of new products and chemicals into workplaces and commerce. The companies represented range from a small brake manufacturer to multinational giants like J&J and Monsanto. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2018 Category: Cancer & Oncology Source Type: news

USC study examines disruption of circadian rhythm as risk factor for diseases
(University of Southern California) USC scientists report a time-keeping mechanism in liver cells that helps sustain key organ tasks can contribute to diseases when its natural rhythm is disrupted. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2018 Category: Cancer & Oncology Source Type: news

Whole-body PET/MRI provides one-stop shop for staging high-risk prostate cancer patients
(Society of Nuclear Medicine and Molecular Imaging) New research shows that molecular imaging--specifically, PSMA PET/MR--performs as well as currently used tools and provides additional information on tumor location that could help guide treatment for prostate cancer patients. The research is featured in the December 2018 issue of The Journal of Nuclear Medicine (http://jnm.snmjournals.org). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2018 Category: Cancer & Oncology Source Type: news

Lethal combination: Drug cocktail turns off the juice to cancer cells
(University of Basel) A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth - this was discovered by researchers from the University of Basel's Biozentrum two years ago. In a follow-up study, recently published in Cell Reports, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 11, 2018 Category: International Medicine & Public Health Source Type: news

Paternal grandfather's high access to food may indicate higher mortality risk in grandsons
(Stockholm University) A paternal grandfather's access to food during his childhood is associated with mortality risk, especially cancer mortality, in his grandson, shows a large three-generational study from Stockholm University. The reason might be epigenetic -- that environmental exposures in one generation may influence health outcomes in following generations. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 11, 2018 Category: International Medicine & Public Health Source Type: news

Taking uncertainty out of cancer prognosis
(Cold Spring Harbor Laboratory) An analysis of nearly 20,000 cancer patient histories and genetic data has revealed that knowing the genetic cause of a cancer does not help predict how deadly the disease will be. Instead, researchers from CSHL have discovered that copy number variations in specific gene sites are far more informative, providing new opportunities to improve prognosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 11, 2018 Category: International Medicine & Public Health Source Type: news

Population Thyroid-Cancer Screening After Nuclear Accidents Not Advisable: Researchers Population Thyroid-Cancer Screening After Nuclear Accidents Not Advisable: Researchers
Thyroid tumors detected by ultrasound screening in Japanese children after the Fukushima Daiichi nuclear accident are similar to those of low-risk, sporadic thyroid tumors seen in adults and therefore are likely not related to radiation exposure, researchers report.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - December 11, 2018 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Higher Risk for Breast Cancer After Childbirth May Last 20 + Years
Risk peaks five years after childbirth but continues until 24 years postbirth (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 11, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Journal, Source Type: news

Eyeballing skin cancer not good enough for accurate diagnosis, say experts
But dermoscopy may help GPs make appropriate referrals, finds Cochrane review Related items fromOnMedica Counsel young people to avoid skin cancer, says US NICE approves new treatment for high-risk skin cancer A.I. better at diagnosing skin cancer than humans Silk garments for skin conditions set to come off NHS prescription (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 11, 2018 Category: UK Health Source Type: news

National lung disease plan needed to help ease winter pressures, experts urge
These illnesses account for nearly one million A&E attendances, with admissions peaking sharply in winter, says British Thoracic Society Related items fromOnMedica Adjuvanted trivalent flu vaccine best option for over-65s UK ‘can and should do better’ in many areas of healthcare UK falls behind other nations in preventing avoidable death Cancer strategies failed to improve one-year survival Lung experts call for ‘national plan for lung cancer’ (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 11, 2018 Category: UK Health Source Type: news

Catnip: The 'Why' Behind Cats' Favorite High
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - December 11, 2018 Category: Cancer & Oncology Source Type: news

Increased breast cancer risk might last decades after childbirth, study says
Compared with women who have never had children, women who have given birth may have an increased breast cancer risk that continues for up to 23 years after their most recent birth, according to a new study published in the journal Annals of Internal Medicine on Monday. (Source: CNN.com - Health)
Source: CNN.com - Health - December 10, 2018 Category: Consumer Health News Source Type: news